Factors associated with mortality in patients hospitalized for COVID-19 admitted to a tertiary hospital in Lambayeque, Peru, during the first wave of the pandemic.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
13
10
2022
accepted:
15
04
2023
medline:
15
5
2023
pubmed:
11
5
2023
entrez:
11
5
2023
Statut:
epublish
Résumé
COVID-19 caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread worldwide, becoming a long-term pandemic. To analyze the factors associated with mortality in patients hospitalized for COVID-19 in a tertiary hospital in the Lambayeque region of Peru. A retrospective cohort study of patients with a diagnosis of COVID-19, hospitalized in a hospital in northern Peru, was conducted from March to September 2020. Of the 297 patients studied, 69% were women, the mean age was 63.99 years (SD = ±15.33 years). Hypertension was the most frequent comorbidity (36.67%), followed by diabetes mellitus (24.67%) and obesity (8.33%). The probability of survival at 3 days of ICU stay was 65.3%, at 7 days 24.2%, and 0% on day 14. Risk factors associated with mortality in patients hospitalized for COVID-19 are age, male sex, tachypnea, low systolic blood pressure, low peripheral oxygen saturation, impaired renal function, elevated IL-6 and elevated D-dimer. Mortality in hospitalized patients with COVID-19 was 51.18 per 100 persons, Mortality was found to be associated with hypertension, type of infiltrating, and sepsis.
Identifiants
pubmed: 37167338
doi: 10.1371/journal.pone.0285133
pii: PONE-D-22-28266
pmc: PMC10174592
doi:
Banques de données
figshare
['10.6084/m9.figshare.21664172.v1']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0285133Informations de copyright
Copyright: © 2023 Aguirre-Milachay et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Med (Lausanne). 2021 May 12;8:623608
pubmed: 34055822
Immun Inflamm Dis. 2022 Mar;10(3):e561
pubmed: 35048534
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
PLoS One. 2022 Mar 8;17(3):e0265089
pubmed: 35259196
J Clin Med. 2022 Aug 02;11(15):
pubmed: 35956109
J Intern Med. 2021 Mar;289(3):411-419
pubmed: 33258156
Cardiovasc Drugs Ther. 2022 Aug;36(4):705-712
pubmed: 33988835
Ann Intern Med. 2021 Jan;174(1):33-41
pubmed: 32960645
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
J Am Med Dir Assoc. 2020 Nov;21(11):1546-1554.e3
pubmed: 33138936
Lancet Rheumatol. 2020 Oct;2(10):e594-e602
pubmed: 32864628
Am J Emerg Med. 2020 Sep;38(9):1722-1726
pubmed: 32738466
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Clin Microbiol Infect. 2020 Nov;26(11):1525-1536
pubmed: 32758659
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
Medwave. 2021 Jul 05;21(6):e8231
pubmed: 34292921
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
PLoS One. 2020 Nov 23;15(11):e0242760
pubmed: 33227019
Ann Med Surg (Lond). 2020 Dec;60:308-313
pubmed: 33169090
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Blood Rev. 2021 May;47:100761
pubmed: 33067035
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Med Virol. 2020 Oct;92(10):1875-1883
pubmed: 32441789
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Thromb Haemost. 2020 Jun;18(6):1421-1424
pubmed: 32271988
PLoS One. 2020 Jul 30;15(7):e0236618
pubmed: 32730358
Crit Care. 2021 Feb 23;25(1):79
pubmed: 33622349
Science. 2020 Jul 17;369(6501):256-257
pubmed: 32675364
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Circulation. 2020 May 19;141(20):e810-e816
pubmed: 32216640
Front Cardiovasc Med. 2020 Aug 06;7:151
pubmed: 32850990
J Med Virol. 2021 May;93(5):2908-2917
pubmed: 33393678
EBioMedicine. 2022 Sep;83:104208
pubmed: 35952496
Infect Dis Now. 2021 Sep;51(6):518-525
pubmed: 34242842
JAMA. 2020 Aug 25;324(8):799-801
pubmed: 32702090
Sci Rep. 2022 Sep 01;12(1):14906
pubmed: 36050403
Br J Clin Pharmacol. 2021 Dec;87(12):4839-4847
pubmed: 33899226
Ann Clin Microbiol Antimicrob. 2022 Mar 25;21(1):14
pubmed: 35337354
Int J Clin Pract. 2021 Sep;75(9):e14467
pubmed: 34107130
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Chest. 2020 Sep;158(3):1143-1163
pubmed: 32502594
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
J Gen Intern Med. 2021 Jan;36(1):17-26
pubmed: 32607928
Nature. 2019 Jul;571(7764):183-192
pubmed: 31292558
JAMA Cardiol. 2020 Jul 1;5(7):743-744
pubmed: 32211809
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120
pubmed: 32172226
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
J Infect Public Health. 2022 May 16;15(6):670-676
pubmed: 35617831
Intensive Care Med. 2020 Jun;46(6):1111-1113
pubmed: 32162032
Rev Peru Med Exp Salud Publica. 2021 Apr-Jun;38(2):214-223
pubmed: 34468567
J Infect Public Health. 2021 Jun;14(6):759-765
pubmed: 34022734
J Clin Lab Anal. 2022 Mar;36(3):e24216
pubmed: 35076953
Trends Endocrinol Metab. 2017 Mar;28(3):199-212
pubmed: 27789101
Front Pharmacol. 2022 Mar 31;13:781192
pubmed: 35431952
PLoS One. 2022 Mar 2;17(3):e0264789
pubmed: 35235613
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712